TELUS Corporation (T:CA) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 12:00 PM EST

Company Participants

Mohamed El-Demerdas

Conference Call Participants

Ryan Rice

Presentation

Ryan Rice

Good morning, everyone. My name is Ryan Rice, and I’m an associate with the JPMorgan Healthcare Investment Banking team. Welcome to the session for TELUS Health. Presenting today, we have the President, Mohamed El-Demerdash. The presentation will be roughly 15 minutes, and then we’ll have a few minutes of Q&A to follow.

With that being said, I’ll leave it over to Mohamed to kick off. All right.

Mohamed El-Demerdas

Thank you. Good morning, everyone. My name is Mohamed El-Demerdash. For those of you who don’t know me, I’m an engineer. I’ve been in the med device industry and health tech broadly for the latter – bigger part of 3 decades. And I got the opportunity to work all sorts of places around the world, developing products, got the opportunity to live outside of North America for about 10 years, delivering services and health care to many around the world.

And it really got me thinking and got me wondering, but from a technology standpoint and the spend, we spend a lot of time, a lot of money on the downstream delivery of acute care diagnosis and therapy. And when you start getting into places where people don’t have access to acute care and the systems are so fragmented, you start thinking what if we had taken the same technologies and start spending it more upstream from a preventive standpoint and start taking advantage of the opportunities for helping people change the trajectory of their health journey earlier upstream. That is fundamentally what TELUS Health does, and that’s what we do.

We’re about preventative health upstream, looking at how we can change